81 results
Page 2 of 5
6-K
EX-10.1
jbl5 qppu3g
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
mvidwpbx
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
rpz9128fox e0j
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-99.1
rtyf v6qcxnr
17 Nov 20
Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors
8:18am
6-K
EX-10.1
72a25jzyths3lq
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
s0h77 u3h06qkv4z5
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-4.2
66042i9f
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
js0a wutf6rbcu2r
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.1
cd8lfjupf
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.1
ux4nie41 vnor3vy2
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-1.1
2f4difn1i5k4o9u80tol
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
UPLOAD
x2bne
3 Feb 20
Letter from SEC
12:00am
20-F/A
EX-12.1
ve5dbjrzxqc5na16
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
cejgl51mhc
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
7v5idz6thx0nr8
31 Jan 20
Annual report (foreign) (amended)
4:31pm